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Abstract.  Members of the rab/YPTI/SEC4  gene family 
of small molecular weight GTPases play key roles in 
the regulation of vesicular traffic between compart- 
ments of the exocyfic pathway.  Using immunoelectron 
microscopy, we demonstrate that a dominant negative 
rabla mutant, rabla(N124I), defective for guanine 
nucleotide binding in vitro, leads to the accumulation 
of vesicular stomatitis virus glycoprotein (VSV-G) in 
numerous pre-cis-Golgi  vesicles and vesicular-tubular 
clusters containing rabl and B-COP,  a subunit of the 
coatomer complex. Similar to previous observations 
(Balch et al.  1994.  Cell. 76:841-852),  VSV-G was 
concentrated nearly 5-1G-fold in vesicular carriers 
that aocumulate in the presence of the rabla(N124I) 
mutant. VSV-G containing vesicles and vesicular- 
tubular clusters were also found to accumulate in the 
presence of a rabla effector domain peptide mimetic 
that inhibits endoplasmic reticulum to Golgi transport, 
as well as in the absence of Ca  2+. These results sug- 
gest that the combined action of a Ca2+-dependent pro- 
rein and conformational changes associated with the 
GTPase cycle of rabl are essential for a late target- 
ing/fusion step controlling the delivery of vesicles to 
Golgi compartments. 
T 
HE  biochemical  mechanisms  underlying  vesicular 
transport between compartments of the exocytic and 
endocytic pathways are poorly understood, but are 
likely to involve the ordered assembly and disassembly  of 
protein complexes that regulate vesicle budding,  targeting, 
and fusion (reviewed in Pryer et al.,  1992; Rothman and 
Orci, 1992). It is now evident that a collection of GTPases 
belonging  to the rab/YPT/SEC4, A~ Sad,  and beterotri- 
meric G~, families serve as molecular switches to control 
diverse functions of the transport machinery (reviewed in 
Goud and McCatfrey,  1991; Barr et al.,  1992; Zerial and 
Stenmark, 1993; Nuoffer and Balch,  1994). In particular, 
transport from the ER to and between Golgi compartments 
in mammalian cells requires the small GTPase rabl. Neu- 
tralizing antibodies (Plutuer et al., 1991; Schwaninger et al., 
1992; Davidson and Balch,  1993; Peter et al.,  1993) and 
rabl-specific  peptides  (Plutner et al.,  1990; Balch et al., 
1993) block transport in vitro. In addition,  trans-dominant 
mutants with altered guanine nucleotide-binding  properties 
inhibit transport in vivo (Tisdale et al.,  1992) and in vitro 
(Nuoffer et al.,  1994; Davidson and Balch,  1993). 
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In a previous study (Nuoffer et al., 1994), we established 
the biochemical and morphological properties of the rabla- 
($25N) mutant, demonstrating that this mutant is likely to 
be restricted to the GDP-bound state, a condition that inhib- 
its vesicle budding and the export of vesicular stomatitis virus 
glycoprotein  (VSV-G)~ from the ER.  Given previous  evi- 
dence that the rabla(N124I) mutant is also a dominant inhibi- 
tor of transport in vivo (Tisdale et al., 1992), we have ana- 
lyzed the effects of this mutant on VSV-G transport in vitro 
using immunoelectron microscopy. We find that the N124I 
mutant is defective for guanine nucleotide binding in vitro, in- 
dicating that it is able to undergo rapid exchange independent 
of  a guanine nucleotide exchange protein (GEP). This mutant 
does not inhibit vesicle budding from the ER. Instead, it pre- 
vents the fusion of VSV-G containing carrier vesicles to the 
Golgi stack.  In the presence of the N124I mutant or in the 
absence of Ca  2+  (by  chelation with  EGTA),  VSV-G ac- 
cumulates in 60-nm carrier vesicles, and clusters of vesicles 
and small tubules-pre-Golgi intermediates that populate the 
normal pathway in vitro (Balch et al., 1994). The combined 
results from this and our previous studies on the rabl(S25N) 
mutant  suggest  that  while  a  conformational change as- 
1. Abbreviations used in this paper: GDI, guanine nucleotide dissociation 
inhibitor;  GEP, guanine nucleotide exchange protein;  ManH, 0~-1,2 man- 
nosidase  II; rabla(N124I),  dominant  negative rabla  mutant;  tsO45, tem- 
perature-sensitive mutant of VSV-G; VSV-G, vesicular stomatitis virus gly- 
coprotein;  VTCs, vesicular tubular  clusters. 
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sary for the recruitment of rabl during vesicle budding, GTP 
hydrolysis  is likely  to be critical  for a late Ca2+-dependent 
vesicle targeting/fusion  step. 
Materials and Methods 
Materials 
A polyclonai reagent recognizing  1)58 was provided by J. Saraste (Saraste 
and Sveusson,  199D.  A monoclonai reagent recognizing  p53 was gener- 
ously provided by H.-P. Hauri (Biocenter, Basel, Switzerland).  Secondary 
antibodies were obtained  form  the foilowing sources: FITC-conjugated  goat 
anti-rabbit F(ab)2 and anti-mouse IgG from Zymed Laboratories, Inc. 
(South San Francisco,  CA); gold-conjugated  goat anti-rabbit from Amer- 
sham Corp. (Arlington  Heights, IL). Rabbit antisera to E-COP were derived 
from  an immunogenic peptide containing the unique EAEG  sequence 
(Duden et ai.,  1991) as described (W'flson, B. S.,  et al.,  1994). 
Preparation of  Recombinant rabla Proteins 
Hiss-tagged  rabla(N124D  protein was  prepared as described (Nuoffer  et 
ai.,  1994). 
Incubation In Vitro  for Morphological  Analysis 
All materials, assays, and procedures used to analyze transport or the mor- 
phological distribution of VSV-G using indirect immunofluorescence  were 
as described previously  using permeabilized NRK cells (Plutner et al., 
1992; Nuoffer et al., 1994). FOr electron microscopy, incubations were con- 
ducted in 35-ram tissue culture dishes (Costar Corp., Cambridge, MA) 
(Baich  et  ai.,  1994).  The analysis of transport using  perforated  cells  based 
on the  processing  of  VSV-G to  endoglycosidase  D- (Beckers  et  al.,  1987) 
or endoglycosidase H-resistant  oligosaccharide  forms (Davidson and 
Balch, 1993;  Nuoffer  et ai.,  1994)  were performed as described. 
Electron Microscopy  and Immunolabeling 
After transport in vitro, permeabilized NRK cells were fixed for 30 rain with 
3 % paraformaidehyde  and 0.1% glutaraldehyde,  pH 7.4, in 0.1 M phosphate 
buffer, washed briefly in PBS,  and processed for immunodiffusion or in- 
direct immunogold labeling of ultrathin cryosections. 
For immanodiffusion, cells were washed for 10 min in PBS containing 
1% BSA, 0.01 M glycine,  and 0.1% saponin, pH 7.4, and then incubated 
sequentially  with a primary monoclonai antibody,  P5D4, specific for the 
cytoplasmic tail of VSV-G (overnight),  a rabbit anti-mouse bridging anti- 
" body (1 h), and 5 or 10 nm gold, goat anti-rabbit IgG conjugate (3 h). After 
washing,  the  ceils  were  fixed  (1  h)  in  3%  paraformaldehyde,  1.5% 
glutaraldehyde,  and 7.5% sucrose in 0.1 M cacodylate buffer, pH 7.4. The 
cells were then pelleted, postfixed  in 1% OsO4 in veronal-acetate buffer, 
stained in block for 2 h in 0.5%  uranyl acetate, pH 6.0, dehydrated,  and 
embedded in el)on. Where indicated, cells were counterstained with tannic 
acid as described (Orci et ai.,  1986). 
For immunogold labeling of ultrathin cryosections,  ceils were harvested, 
pelleted, and cryoproteeted  by infiltration with a mixture of 2.3 M sucrose 
in 0.1 M phosphate buffer, pH 7.4, containing 20% polyvinyl pyrrolidone, 
mounted on  aluminum nails,  and  frozen in liquid nitrogen.  Ultrathin 
cryosections  were cut on a Reicbert Ultracult E, equipped with a Reichert 
FC-4  cryoattachment, collected  on  formvar/carbon-coated  nickel  grids,  and 
quenched in 0.01 M glycine,  pH 7.4. Sections were then incubated 2 h at 
room  temperature  with  the  anti-VSV-G  monoclonai  antibody  in  10% 
FCS/PBS,  a rabbit anti-mouse bridge (1 h), followed by a 5-nm gold, goat 
anti-rabbit IgG conjugate (2 h). The grids were then stained in 2 % neutral 
uranyl acetate (10 rain) and subsequently adsorption-stained  with 0.2 % ura- 
nyl acetate, 0.2%  methyl cellulose,  and 3.2%  polyvinyl alcohol.  Sections 
were observed on an electron microscope (1200 EX; JEOL U.S.A.  Inc., 
Peabody,  MA,  or  CM-10;  Philips  Electronic  Instruments  Co.,  Mah- 
wall, NJ). 
Quantitation 
Electron micrographs were enlarged to a magnification of 50,000-100,000- 
fold. The linear membrane density was determined by tracing of the mem- 
brane contour length of each compartment on photographic prints with aid 
of a measuring pen calibrated to give the total millimeter length for a partic- 
ular magnification.  For both vesicular-tubular clusters (VTCs) and Golgi 
stacks, only the external membrane length reflecting the distribution of gold 
particles was traced. The numbers reported are the number of gold particles 
per millimeter of membrane length of the compartment traced with the pen. 
In the case of 40-80-nm vesicles, the mean linear density is reported as that 
calculated for a 60-nm vesicle.  The data presented for the distribution of 
VSV-G in the different intermediates and the Golgi for each time point in 
Fig. 2 are the combined averages of between two and three separate experi- 
ments. The error bar in each of these experiments reflects a number of vari- 
ables that include the combined averages from different experiments,  varia- 
tion in the degree of infection of individual cells,  and differences in rates 
of transport in vitro of VSV-G in different  cells within each experiment. 
Statistical  significance of data was determined by a Student's  t test. 
Results 
VSV-G Protein Accumulates in Carrier Vesicles and 
VTCs in the Presence of GTPvS 
We have recently established that VSV-G is sorted and con- 
centrated into 60-rim carrier vesicles upon export from the 
ER (Balch et al., 1994). To examine the role of GTP hydroly- 
sis in protein  concentration  and vesicle budding  from the 
ER, we first examined the effect of the nonhydrolyzable GTP 
analogue, GTP3,S, on the export of VSV-G using quantitative 
immunoelectron microscopy  and  an  assay  that efficiently 
reconstitutes this stage of the secretory pathway in vitro using 
permeab'dized NRK cells (Plumer et al., 1992). For this pur- 
pose and to synchronize  the export of VSV-G from the ER, 
we used a temperature-sensitive  mutant of VSV-G (tsO45) 
which has a thermoreversible  folding defect and is retained 
in the ER when cells are held at the restrictive temperature 
(Lafay, 1974). After shifting the ceils to the permissive tem- 
perature (32°C), tsO45 VSV-G is efficiently  transported to 
the Golgi stack in rive (Tisdale  et al.,  1992) and in vitro 
(Plumer et al.,  1992; Balch et al.,  1994). 
When permcabilized NRK  cells  containing tsO45 VSV-G 
in the ER were incubated for  45 min at  the permissive tem- 
perature in the presence of GTP-rS, and the distribution  of 
VSV-G was analyzed  by immunoelectron microscopy, VSV-G 
was not  detected  in  Golgi elements (Fig. I  B). Instead,  VSV-G 
was found in  both carrier  vesicles  and  clusters  of  vesicles  and 
small tubular  elements (VTLS) (Fig. I, A-C). Carrier  vesi- 
cles and VTCs that  accumulate in the presence of GTP-~S 
were identical  to those  previously shown to be pre-Golgi 
transport  intermediates  under normal incubation  conditions 
in vitro  (Baich et al., 1994). However, in the presence of 
GTPTS,  VTCs not only contained fewer tubular elements 
than intermediates  observed at  a similar  time point  in  the  ab- 
Figure I. GTP,/S, EGTA and a rabl effector domain peptide cause accumulation of VSV-G protein in pre-Golgi intermediates. VSV-G is seen 
in  transport  vesicles  and VTCs after  incubation  for  45 rain  at  32°C in  the  presence of I0 ~tM GTP'yS (A-C), and in  VTCs after  incubation 
(45 rain,  32°C) in the presence of 25 ~tM rab3AL (E) or I0 mM  EGTA  (D and F) as described in the Materials and Methods, In the 
presence of  GTPTS (B) or  EGTA  (F),  VSV-G is  not transported  to  the Golgi. Methods for  labeling  and immunoclectron microscopy using 
the immunodiffusion protocol were as described in Materials and Methods. Bar,  0.1 /~m in A, B, D, and ~,, and 0.05 ~m in C and E. 
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incubation in vitro in the presence of transport  inhibitors.  Perme- 
abflized cells were incubated for 45 min in the presence of 10 ~,M 
GTP~S,  10 mM EGTA,  25 ~M rab3AL peptide  (Phitner  et al., 
1990),  or rabla(N124I)  (1  /~M), and the mean linear  density of 
VSV-G (number  of gold particles  per micrometer of membrane 
contour length) in the ER, ER to Golgi carrier vesicles, VTCs, and 
the Golgi stack was determined as described in the Materials and 
Methods. ER to Golgi carrier vesicles were identified as 40-80-nm 
structures that contained >1 gold particles.  The error bars define 
the SEM reflecting the distribution  range of VSV-G in individual 
compartments used to generate the mean value as indicated in the 
Results. The total number of gold particles  counted for each ex- 
perimental condition are indicated at the top of  the figure. The data 
presented for the distribution of VSV-G in the different intermedi- 
ates and the Golgi for each time point are the combined averages 
of  between two and five separate experiments. Within an individual 
experiment or within individual cells examined at high resolution, 
the  fold change in density of VSV-G over that found in the ER 
ranged from 5.2 to 22 (nine experiments) in VTCs and 4- to 24-fold 
(four experiments) in the Golgi stack,  nd,  none detected. 
sence of inhibitor (Balch et al.,  1994),  but showed a  high 
content  of  vesicular  profiles,  suggesting  that  they  were 
largely composed of  clusters of  60-rim vesicles (Fig. 1, A and 
C). Vesicles  and VTCs containing  VSV-G formed in  the  ab- 
sence (Balch et  al.,  1994) or  presence of  GTP3,S also  con- 
tained smooth dense coats (Fig. I C). VTCs are the high 
resolution counterpart to the numerous punctate, pre-Golgi 
structures previously detected using indirect immunofluores- 
cence in vitro in the presence of GTP~S (Schwaninger et al., 
1992). 
To ascertain whether VSV-G was concentrated in vesicles 
and VTCs in the presence of GTP3,S to a similar degree as 
that observed under normal incubation conditions (Balch et 
al., 1994), the mean linear membrane density of VSV-G was 
determined using immunoelectron microscopy. As shown in 
Fig. 2 A, the mean linear density of VSV-G in isolated carrier 
vesicles formed in the presence of GTP'vS was 25.8  +  15.8 
gold particles//~m (assuming a 60-nm vesicle). These vesi- 
cles bad an average of 5.0  +  3.1 gold particles/vesicle (298 
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lqgure 3. Quantitative analysis of the distribution of VSV-G along 
the membrane contour length of the ER or in carrier vesicles. (,4) 
The distribution of VSV-G in the ER membrane before incubation 
in vitro (open bars) (five experiments,  78 fields) or after 45 rain 
in the presence of  GTP3,S (solid bars) (three experiments, 48 fields) 
as described in the Materials and Methods is reported as the num- 
ber of gold particles detected as individual particles or in groups 
of  two or more particles (see Results). (B) The number of gold par- 
ticles in individual vesicles after 5 rain incubation in vitro (open 
bars) (two experiments, 29 fields) or after 45-rain incubation in the 
presence of GTP'yS (solid bars) (three experiments,  48 fields). 
vesicles counted) (Fig. 3 B, solid bars). These numbers are 
comparable to those obtained for vesicles formed after only 
5  min of incubation in the absence of inhibitor (Fig.  3 B, 
open bars vs solid bars) (Balch et al.,  1994). The mean lin- 
ear density of VSV-G in these VTCs was 37.1 +  20.6 gold 
particles//~m (with  an  average of 30.8  +  11.8 gold parti- 
cles/VTC, 44 VTCs counted) (Fig. 2 A). Even after a 45-min 
incubation at 32°C in the presence of GTP3,S, the concentra- 
tion of VSV-G in the ER (6.1  +  3.4 gold particles/inn) (Fig. 
2 A) was not significantly different (P <  0.001) from that ob- 
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(Balch et al., 1994). These results suggest that while vesicle 
budding occurs in the presence of GTP3~S, transport compo- 
nents present in the assay may be unable to efficiently recycle 
in the absence of GTP hydrolysis, thereby reducing the over- 
all extent of export from the ER compared to normal incuba- 
tion conditions in the absence of the inhibitor. 
To assure ourselves that the increased linear density of 
VSV-G in vesicles or VTCs formed in the presence of GTPTS 
was not a consequence of an unusual change in its linear dis- 
tribution throughout the ER membrane before vesicle bud- 
ding,  we assessed the distribution of gold particles as in- 
dividual particles or groups Of  particles on the ER membrane 
in the presence or absence of the inhibitor (Fig. 3 A). Even 
after a 45-rain incubation in the presence of GTP~/S, gold 
particles remaining in the ER membrane were found to be 
distributed predominantly as individual particles. 819 out of 
1,048 particles or groups of particles detected were scored 
as individual particles (Fig.  3 A). In this experiment, the 
mean distribution of gold particles retained in the ER in the 
presence of GTP-/S was found to be 1.5 +  1.1 gold particles/ 
group (Fig. 3 A, solid bars). This result is not significantly 
different (P <  0.01) from our previous results, which docu- 
mented the distribution of gold particles in the ER before in- 
cubation in vitro in the absence of GTP3,S (Fig. 3 A, open 
bars) (1.5  +  1.2 gold particles/group) (Balch et al.,  1994). 
Thus, incubation in the presence of GTPTS does not lead to 
a general aggregation of VSV-G along the surface of the ER 
membrane. Concentration is closely coupled to vesicle bud- 
cling.  Moreover,  the  5-  to  10-fold increase in density of 
VSV-G in vesicles and VTCs in the presence of inhibitor is 
comparable to the increased concentration of  VSV-G in iden- 
tical structures formed in the absence of inhibitor (Balch et 
al.,  1994). 
The Rabla(N124I) Mutant is Defecave  in Guanine 
Nucleotide Binding and Biochemically Distinct  from 
the Rabla(S2$N) Mutant 
To analyze specifically the role of tab1 in vesicle targeting 
and fusion, we explored the properties of the rabla mutant, 
in which the asparagine in position 124 Of the third guanine 
nucleotide binding motif (NKXD) is substituted by isoleu- 
cine. The N124I mutant has a number of properties that dis- 
tinguish it from those of the rabla(S25N) mutant, which has 
a preferential affinity for GDP (Nuoffer et al.,  1994). First, 
the rabla(N124I) mutant fails to bind both GDP or GTP at 
detectable levels in vitro (Table I). The equivalent mutation 
in H-ras(N116I) is similarly defective for GDP/GTP binding 
and is transforming, suggesting that it causes constitutive ac- 
tivation a consequence of  a GEP-independent, high exchange 
rate (Walter et al., 1986). Second, the N124I mutant is a po- 
tent inhibitor of ER to Golgi transport when transiently ex- 
pressed in vivo (Fig. 4, lane c), even in the absence of the 
carboxyl-terminal CC motif (Fig. 4, lane d), suggesting that 
isoprenylation is not essential for function. However, further 
truncation of the carboxyl terminus leads to loss of inhibi- 
tory activity (Fig. 4, lane f), reflecting either the require- 
ment for the hypervariable domain for membrane localiza- 
tion  or,  alternatively,  misfolding  and  instability  in  vivo. 
Third, the dominant negative effects of  the rabla(N124I) mu- 
tant were not sensitive to coexpression with wild type rabla 
in vivo (Fig. 4, lane e), suggesting that it functions in an irre- 
Table I.  Guanine Nucleotide Binding to Purified  WiM 
Type and Mutant Rab la 
Bound nucleotide  (tool/tool) 
I-Iis~-rab  la  ¢xP2p]GTP  [~H]GDP 
Wild type  0.85  0.27 
N124I  <0.01  <0.01 
Guanine nuclcofide binding to purified wild type and mutant rabla. Hise- 
tagged wild type  and mutant rabla were  purified  as described  (Nuoffer  et al., 
1994), and 31-pmol  (0.7-t~10  allquots  were  incubated  for 45 min at 30°C in an 
assay buffer  comprising 50 mM Hepes-potassinm  hydroxide,  pH 8, 5 mM 
EDTA, 2 mM MgCI2, 1 mM DTT, 0.1 #g/ml BSA, and either 1.4 #M 
[3H]GDP (specific  activity = 3 Ci/mmol)  or 1.1/tM a~P]GTP (specific  ac- 
tivity ffi 6 Ci/mmol)  (final  vol ffi 100 td). Nucleotide  exclmnge  was termimm.d 
by the addition of e~cess MgCIz, and bound nuclcotide measured by fiquid 
scintillation counting after capture of the protein on 0.45/an nitrocellulose 
membranes (BA85; Schleicher  & Schuell, Inc., Keene, Nil). 
versible  fashion.  Finally,  the  intact rabla(N124I)  mutant 
failed  to  incorporate  pH]geranylgeranylpyrophosphate 
when incubated in the presence of cytosol prepared from rat 
liver homogenates (data not shown). Given the previous ob- 
servation that additional secondary or tertiary structure is es- 
sential for the geranylgeranylation of  CC- and CXC-contain- 
ing proteins (Khosravi-Far et al., 1991,  1992), it is apparent 
that the conformation of the N124I mutant is different from 
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Rgure 4. The N1241 mutant inhibits transport irreversibly and does 
not require prenylation for dominant negative function in vivo. 
HeLa cells were infected with the T7 RNA polymerase-recom- 
binant vaccinia virus vTF7-3 and cotran.~ected with plasmids en- 
coding VSV-G and the indicated rabla constructs as described pre- 
viously (Nuotfer et al.,  1994). After 5-h transfecfion, coils were 
pulse-labeled with trans-~SS label for 10 min, not chased 0ane a) 
or chased for 60 min (lanes b-f). VSV-G  was immtmoprecipitated, 
digested with endo H, and the endo H-sensitive, the endo H-resis- 
tant intermediate, and the terminally glycosylated forms were sepa- 
rated by SDS-PAGE. Autoradiographs were quantitated by scan- 
ning densitometry as described previously (Nuotfer et al., 1994). 
Transport is expressed as the percentage of total VSV-G converted 
to endo H-resistant forms. Lanes a and b show cells transfected 
with VSV-G  only; in lanes c-f, cells were cotransfected with VSV-G 
and the indicated plasmid(s). In lane e, cells were transfected with 
both rabla(N124I)  and rabla-wt. In all cases, expression levels of 
wild  type and  mutant  proteins  (about  two- to eightfold) were 
confirmed using Western blotting (data not shown). 
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Accumulation of VSV-G in Pre-Goigi Carrier Vesicles 
and VTCs In Vitro 
To assess directly the consequences of the rabla(N124I)  mu- 
tant on ER to Golgi transport, the effects of the mutant on 
the processing of VSV-G oligosaccharides to the cis-Golgi, 
endoglycosidase D-sensitive form was analyzed in vitro. In 
this case, perforated 15B CHO cells were incubated in the 
presence of  cytosol at the permissive temperature in the pres- 
ence  of recombinant rabla(N124I)  prepared  from Esche- 
richia coli (Nuoffer et al.,  1994).  As shown in Fig. 5 A, 
rabla(N124I)  strongly inhibited transport in vitro in a dose- 
dependent fashion with half-maximal inhibition occurring at 
,~400 ng (final concentration  =  0.5  t~M). Inhibition was 
abolished if  the protein was denatured by boiling before addi- 
tion to the assay. Preincubation of the mutant in the presence 
of  cytosol reduced the amount of  mutant protein required for 
half-maximal inhibition by ,~50%, suggesting that cytosolic 
factor(s) may participate in establishing the inhibitory phe- 
notype of the rabla(N124I)  mutant (data not shown). 
Analysis of  the temporal sensitivity of  the transport reaction 
to the rabla(N124I)  mutant revealed that transport could be 
inhibited only at early, but not late times of incubation (Fig. 
5 B). Cells incubated in the absence of the inhibitor rapidly 
became insensitive to the subsequent addition of the mutant 
protein. For example, >50% of  maximal transport activity  be- 
came resistant to the addition of the rabla(N124I) mutant dur- 
ing the first 15 min of incubation (Fig. 5 B, closed squares), 
a time point at which <10% of the VSV-G had reached the 
cis-Golgi compartment and processed to the endoglycosi- 
dase D-sensitive form (Fig. 5 B, open squares). Given that 
the first 20 min of incubation in vitro is the time period dur- 
ing which VSV-G is sorted and concentrated via 60-nm car- 
rier vesicles (Baich et al.,  1994),  these results raised two 
possibilities. Either the N124I mutant inhibits vesicle bud- 
ding per se, or the mutant protein (or a rabl-regulated trans- 
port factor) needs to be recruited during vesicle formation 
to function at a later vesicle targeting/fusion step. 
To distinguish between these two possibilities,  the transport 
of tsO45  VSV-G was examined in vitro using indirect im- 
munofluorescence after incubating permeabilized NRK cells 
at 32°C in the presence or absence of mutant protein. As ex- 
pected, before the start of the incubation, tsO45 VSV-G was 
restricted to the ER (Fig.  6 A) and could not be detected in 
the Golgi stack, based on the distribution of the cis/medial 
Golgi marker o~-1,2 marmosidase II (Man 1/) (Velasco et al., 
1993) (Fig. 6 B). Incubation in the absence (Fig. 6, C and 
D) or presence of excess wild-type rabla (Fig. 6, E-J) led 
to the redistribution of VSV-G from the ER to pre-Golgi 
punctate structures that overlapped with p58 (Fig. 6, E [VSV- 
G]  and  F  [p58]),  a  marker  for  pre-Golgi  intermediates 
(Saraste et al., 1987; Saraste and Svensson, 1991) and to the 
Golgi compartments containing Man II  (Fig.  6,  G  and I 
[VSV-G] and H and J [Man II]). In contrast, in the presence 
of the rabla(N124I)  mutant, while the Golgi stack remained 
intact, overlap of VSV-G with Man II was largely abolished 
(Fig. 6, M [VSV-G] and N [Man II]; arrows, Golgi compart- 
ments), a result consistent with the biochemical data (Fig. 
5).  However,  the N124I mutant, unlike the $25N  mutant 
(Nuoffer et al.,  1994),  did not affect the export of VSV-G 
from the ER to p58-containing pre-Golgi intermediates (Fig. 
6,  K  [VSV-G] and L  [p58],  arrowheads).  Using  confocal 
Figure 5. Inhibition of vesicular transport in vitro by rabla(N124I). 
(,4) Vesicular  transport between  the ER and cis-Golgi in perforated 
15B CHO cells was measured as described previously (Beckvrs et 
al.,  1987). Assay mixtures were supplemented with the indicated 
amounts of rabla wild type (i) or rabla(N124I) (n). The inset shows 
SDS-PAGE analysis of 2 #g of the purified mutant protein stained 
with Coomassie  blue. (B) Temporal sensitivity  of VSV-G transport 
to rabla(N124I). At the times indicated, the assays were shifted to 
ice, and the cells collected by centrifugation  (3 rain at 500 g). The 
membranes were resuspcnded in fresh reaction mixture,  s supple- 
mented with 1.25/~g rabla(N124D and either maintained  on ice (n) 
or incubated at 320C for the remainder of a total of 90 rain (,l). 
microscopy, the extent of overlap of VSV-G with p58-con- 
taining structures was '~75%,  with <5-10%  overlap with 
Man H-containing Golgi compartments. 
Using immunoelectron microscopy, we next identified the 
pre-Golgi structures accumulating VSV-G in the presence of 
the rabla(N124I)  mutant after a 45-min incubation at the per- 
missive temperature in vitro. VSV-G was exported from the 
ER and accumulated in vesicles and numerous VTCs with 
a high proportion of vesicular profiles (Fig. 7, A and C-D). 
As shown in Fig. 2 B, the mean linear densities of VSV-G 
in  vesicles  (34.5  +  18.8 gold  particles//zm,  36  vesicles 
counted) and VTCs (29.7 +  11.8 gold particles//~m, 37.1 + 
17.0 particles/VTC; 44 VTCs counted) in the presence of 
rabla(N124I)  were similar to the density observed in vesicles 
in the absence of the mutant protein after 15 min incubation 
at the permissive temperature (29  +  17 gold particles//~m; 
Balch et ai., 1994).  However, the N124I mutant completely 
blocked transport of VSV-G to Golgi stacks (Fig. 7 A,/arge 
arrows).  Quantitation revealed that the  linear  membrane 
density of VSV-G in Golgi stacks was only 1.2  +  1.3 gold 
particles//~m  (two gold particles per stack, 28 Golgi stacks 
counted) (Fig. 2 B). No inhibition of  transport to the cis face 
of the Golgi stack was observed in the presence of excess 
wild type rabla  (Fig.  7  B),  a  result consistent with the 
The Journal of Cell Biology, Volume 125,  1994  244 Figure 6. VSV-G accumulates in p58-containing intermediates in the presence of rabla(N124I). Permeabilized NRK cells were maintained 
on ice (A and B) or incubated at 32°C for 80 rain in the absence of recombinant rab protein (C and D), the presence of rablb wild type 
(2 #M) (E-J), or rabla(N124D (2 #M) (K-N) as described in the Materials and Methods. The distribution of VSV-G, Man II (a marker 
for the medial Golgi), or p58 (a marker for pre-Golgi intermediates in NRK cells) was determined by indirect immunofluorescence. A, 
C, E, G, I, K, and M show the distribution  of VSV-G; B, D, H, J, and N show the distribution  of Man II; F and L show the distribution  of p58. 
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of  wild type rabla (Fig. 5). Thus, in contrast to the $25N mu- 
tant, N124I mutant inhibits exclusively a late vesicle target- 
ing/fusion step. 
A  Peptide Identical to the Effector Domain of 
Rabla Inhibits Transport and Accumulates VSV-G 
inVTCs 
Consistent with a role for rabl in vesicle targeting/fusion, we 
previously observed a late block in transport using a  syn- 
thetic peptide identical to the effector domain of rabl (Plut- 
net et al.,  1990;  Balch et al.,  1993).  When examined us- 
ing  indirect  immunofluorescence (Plutner  et  al.,  1990; 
Schwaninger et al., 1992), incubation of perforated cells with 
this peptide mimetic leads to the accumulation of VSV-G in 
punctate pre-Golgi structures.  Using immunoelectron mi- 
croscopy, we found that incubation in the presence of the 
effector domain peptide led to the accumulation of VSV-G 
in VTCs morphologically similar to those observed in the 
presence of the rabla(N124I)  mutant (Fig. 1 E). The mean 
linear density of VSV-G in these VTCs was 30.5  +  11 gold 
particles//~m with an  average of 26.1  +  10.4 gold parti- 
cles/VTC (19 VTCs examined) (Fig. 2 C). Consistent with 
the  efficient  inldbition  of  transport  by  the  peptide,  no 
significant transport to the Golgi stack could be detected 
(Fig. 2 C). Moreover, little VSV-G could be detected in inde- 
pendent carrier vesicles (Fig. 2 C), and the profiles of most 
VTCs were vesicular rather than tubular in shape (Fig. 1 E). 
These results are consistent with the possibility that the pep- 
tide may sequester the function of an effector protein re- 
quired for a late vesicle targeting or fusion step. 
Rabl and ~-COP Colocalize with VSV-G in VTCs 
We have recently provided biochemical evidence that the 
nonclathrin coat protein B-COP (Duden et al., 1991; Serafini 
et al., 1991; Waters et al., 1991; Orci et al., 1993) is essential 
for export of VSV-G from the ER and may be recruited coor- 
dinately with rabl as part of an 18 to 19S precoat particle 
(Peter et al., 1993). These results predict that the coat struc- 
ture present on vesicles and VTCs should contain both rabl 
and B-COP. Using an antibody specific for B-COP, both vesi- 
cles and budding profiles at the tips of cisternae and along 
the c/s face of the Golgi stack labeled strongly for B-COP 
in perforated cells incubated for 30 min at 32°C in vitro (Fig. 
8 A). In addition, VTCs containing VSV-G found either adja- 
cent to the nucleus (Fig. 8 B) or in more peripheral locations 
(not shown) contained B-COP.  Similarly, rabl  colocalized 
with VSV-G on the external surface of VTCs (Fig. 8 C) and 
on the as~medial compartments of Golgi stacks (data not 
shown). This degree of colocalization is consistent with our 
previous observations that rabl and B-COP are abundant on 
pre-Golgi punctate intermediates and Golgi stacks based on 
indirect immunofluorescence (Plutner et al., 1992; Schwan- 
inger et al.,  1992). 
To insure that the VSV-G- and B-COP-containing vesicles 
observed in Fig. 8 A were not derived from vesicles budding 
from early Golgi compartments, the distribution of ~-COP 
was examined in cells incubated in the presence of GTP3,S. 
As expected, under these conditions, the Golgi stack was de- 
void of VSV-G (compare Fig.  8 D  to Fig.  8 A),  although 
B-COP containing budding profiles at the tips of  Golgi cister- 
nae, as well as numerous B-COP containing vesicles lacking 
VSV-G, could be detected along the proximal face. Despite 
the clear transport block,  VSV-G containing vesicles and 
VTCs derived from the ER also labeled strongly for B-COP 
(Fig.  8,  E-H).  The  combined  results  establish  that  the 
p58-containing  vesicular carriers  mediating ER to  Golgi 
traffic in vitro (Balch et al.,  1994)  contain both rabl  and 
B-COP. 
VSV-G Accumulates in Carrier Vesicles and VTCs in 
the Absence of Ca  z+ 
In yeast, the function of the rabl homologue Yptlp has been 
reported to be sensitive to cytosolic Ca  2+ (Schmitt et al., 
1988).  Moreover, mutant alleles of PRM1, a Ca  2+ ATPase 
present in the Golgi, are strong suppressors of yptl-1 defects 
in ER to Golgi transport (Rudolph et al., 1989).  Consistent 
with a potential role for Ca  2+ in ER to Golgi transport, we 
have previously demonstrated that EGTA is a potent inhibi- 
tor of transport in vitro (Beckers and Balch, 1989; Beckers 
et al.,  1990). 
The effect of incubation of perforated cells at the permis- 
sive temperature in the absence of Ca  :+ is shown in Fig.  1. 
VSV-G was efficiently exported from the ER, but was found 
to accumulate in tightly packed VTCs (Fig. 1, D and F). As 
was the case with GTP3,S (Fig. 1, A-C), VTCs formed in the 
presence of EGTA show a high proportion of vesicular pro- 
files compared to tubular profiles with a mean linear mem- 
brane density of 31.7 ±  9.4 gold particles//~m  (Fig. 2 D). 
However, VTCs accumulated in the presence of EGTA had an 
average  value of 75  +  26.4  gold particles/VTC (17  VTCs 
counted). The latter number is indicative of the larger size of 
the v'rCs formed in the presence of EGTA compared to those 
observed under normal transport conditions at the same time 
point (21  ±  19 gold particles/VTC; Balch et al.,  1994) or 
in the presence of GTP3,S (30.8 +  11.8 gold particles/VTC). 
Moreover, there was a statistically significant (P =  0.01) de- 
crease in the linear density of VSV-G in the ER (1.5 +  1.62 
gold particles/~m membrane length) (Fig. 2 D), compared 
to that observed before incubation (5.2  ±  2.1; Balch et al., 
1994) or in the presence of GTPTS (Fig. 2 A), indicating that 
VSV-G was efficiently exported from the ER in the absence 
of cytosolic Ca  2+. The combined results suggest that Ca  2+ is 
Figure 7. VSV-G accumulates in pre-Golgi VTCs in the presence of rabla(N124I). Digitouln-permeabilized  NRK cells were incubated at 
32°C for 45 min in the presence of rabLa(N124D (2 ~,M) (A, C, and D) or wild-type rabla (2 t~M) (B) as described in the Materials and 
Methods. In cells incubated with the rabla mutant VSV-G accumulates in VTCs (arrowheads) and does not reach the Golgi stacks (/arge 
arrows). C and D show enlargements  of VTCs that accumulate in the presence of  mutant protein. Methods for labeling and immunoelectron 
microscopy using the immtmodiifusion  protocol were as described in Materials and Methods. Bar, 0.1 tzm in A; 0.05 t~m in B; and 0.02 
tim in C and D. 
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rabl  function. 
Discussion 
The Rabla(N124I) Mutant Inhibits 
Vesicle Targeting/F~sion 
Incubation of perforated NRK cells in the presence of the 
rabla(N1241)  mutant led to the accumulation of VSV-G in 
pre-Golgi vesicles and VTCs, efficiently inhibiting delivery 
to the Golgi stack. Similarly, transient expression of rablb- 
(N121I) (a functionally  equivalent isoform with 92 % identity 
to rabla) in HeLa cells led to the accumulation of VSV-G in 
punctate, pre-Golgi structures that overlap with the distribu- 
tion of the pre-Golgi intermediate marker protein p53 (Tis- 
dale et al., 1992) (Plutner, H., and W. E. Balch, unpublished 
observation) (Schweizer et al., 1988). Consistent with these 
results, the yeast counterpart of rabl, Yptlp, has also been 
suggested to be required for a late vesicle targeting/fusion 
step in vivo and in vitro (Segev et al.,  1988;  Bacon et al., 
1989; Kaiser and Schekman, 1990;  Rexach and Sehekman, 
1990;  Segev,  1991). Moreover,  Yptlp  has  recently been 
shown to be a component of 50-nm carrier vesicles involved 
in ER to Golgi transport (Lian and Ferro-Novick,  1993). 
Thus, it is apparent that the presence of the N124I mutant 
blocks transport in a dominant fashion by preventing interac- 
tion of the endogenous wild type rabl with a transport com- 
ponent(s) required for the targeting or fusion of transport 
vesicles with the cis-Golgi compartment. 
What is the defect in rabla(N124I)  function responsible for 
this phenotype? The equivalent H-ras (Nll6I) mutant is trans- 
forming, suggesting that this mutation leads to constitutive 
activation (Walter et al., 1986). Based on the inability of  both 
mutants to bind GDP or GTP in vitro and the structural con- 
servation of ras-like GTPases, the N124I mutation may have 
a similar effect on rabla. If so, the ability of carrier vesicles 
to form, but not fuse, may reflect an alteration in the confor- 
mation of the rabl mutant which prevents its normal cycling 
from the GTP-bound to the GDP-bound form. In the absence 
of such a conformational switch, late events regulating vesi- 
cle targeting/fusion fail to be initiated. Since we have not 
directly demonstrated that the mutant is actively recruited 
during vesicle budding, two sites of action are currently pos- 
sible. Either the mutant is recruited during vesicle budding 
in place of endogenous wild type rabl, or alternatively, the 
mutant binds directly to a downstream component required 
for vesicle targeting/fusion, thereby preventing completion 
of the transport cycle by vesicles containing wild type rabl. 
Interestingly, the rabl effector domain peptide inhibits trans- 
port at an identical step.  Whether the component inhibited 
by rabla(N124I)  mutant and that sensitive to the peptide are 
identical remains to be determined. 
Sorting and Concentration Is Complete upon Vesicle 
Budding from the ER 
We previously demonstrated (Balch et al., 1994) that the only 
concentration step detectable in the transport of VSV-G to 
the trans Golgi network occurs during vesicle budding from 
the ER. In the present study, we detected no significant in- 
crease in the concentration of VSV-G in vesicles or VTCs ac- 
cumulating in the presence of the rabla(N124I) mutant or in- 
hibitors that block the fusion of carrier vesicles or VTCs to 
the Golgi stack. These results are consistent with the inter- 
pretation that sorting and concentration of VSV-G is com- 
pleted upon budding from the ER (Balch et al., 1994). They 
argue against the possibility that concentration may occur as 
a result of, for example, recycling of membrahe and lipid via 
additional rounds of budding from tubular elements pres- 
ent in  VTCs.  The results  also provide  evidence that the 
rabla(N124I)  mutant, the effector domain peptide and the ab- 
sence of Ca  2+ lead to the accumulation of a  common pre- 
Golgi intermediate by blocking the normal transport process. 
Since rabl is also required for transport between Golgi com- 
partments (Nuoffer et al., 1994; Davidson and Balch, 1993), 
steps  in  which  further  concentration cannot be  detected 
(Orci et ai., 1986; Balch et al., 1994), it is presently unclear 
whether rabl per se is directly involved in protein sorting or 
concentration. However,  a number of other small GTPases 
including Arf (Balch et al., 1992; Dascher and Balch, 1994) 
and Sarl (Nakano and Muramatsu, 1989; Oka et al., 1991; 
d'Enfert et al.,  1991; Barlowe et al.,  1993;  Kuge et al., 
1994), as well as an unknown G~, (s) protein (Schwaninger 
et al.,  1992) are essential for export from the ER in mam- 
malian cells. These proteins and/or their associated machin- 
eries are currently reasonable candidates for the regulation 
of steps related to protein sorting and concentration. 
Role of VTCs in ER to Golgi Transport 
Carrier vesicles budding from the ER of NRK cells rapidly 
(within 5-10 rain) organize into VTCs in vitro (Balch et al., 
1994),  which are similar in structure to putative pre-Golgi 
elements containing p58 in intact cells (Saraste and Svens- 
son, 1991). A characteristic of  both p53- and p58-containing 
pre-Golgi  intermediates in vivo (Schweizer  et al.,  1991; 
Saraste and Svensson, 1991), or those observed here in vitro, 
is the presence of short tubular elements. More extensively 
tubulated or vacuolated pre-Golgi elements have been ob- 
served to accumulate nascent membrane and secretory pro- 
teins upon incubation at reduced temperature (Saraste and 
Kuismanen, 1984;  Saraste et al., 1986;  Saraste and Svens- 
Figure 8. Rabla and/3-COP colocalize with VSV-G in VTCs. (A-C) Permeabilized NRK cells were incubated for 30 min at 32°C as de- 
scribed in Materials and Methods. (A) Distribution of/~-COP (arrows, large gold) and VSV-G (arrowheads, small gold) in the Golgi stack. 
/~-COP is prominent on the cis face of the Golgi and on peripheral vesicles. (B) Enlargement of/3-COP- (large gold) and VSV-G- (small 
gold) containing VTCs showing  colocalization of/~-COP and VSV-G. (C) Colocalization of rablb (arrows, large gold) and VSV-G (arrow- 
heads, small gold) in VTCs. (D-F) Permeabilized NRK cells were incubated for 45 rain at 32°C in the presence of GTP3,S. (D) A Golgi 
region lacking VSV-G. (E-F) ER-derived vesicles and VTCs contain both VSV-G (arrowheads, small gold) and/~-COP (large gold). 
Methods for labeling and immunoelectron microscopy using the immunodiffusion  protocol (C) or ultrathin cryosections (A-B and D-H) 
were as described in Materials and Methods. Bar, 0.05 #m in A-H. 
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or during virus infection, particularly using viruses which 
mature in pre-Golgi intermediates (Tooze et al.,  1984;  So- 
deik et al., 1993; Krijnse-Locker et al., 1994).  We suggest 
that the morphology of pre-Golgi intermediates observed in 
different cell lines, in the presence of selected viruses and 
under different incubation conditions, is likely to vary con- 
siderably  reflecting rate-limiting  step(s)  in  either  vesicle 
budding  from the  ER  or  in  the  targeting  and  fusion of 
peripherally derived 60-nm carrier vesicles to the perinu- 
clear cis-Golgi compartment. Our results are most consis- 
tent with the interpretation that transport between the ER 
and the cis-Golgi compartment involves a  single round of 
vesicle budding/fusion. Since VTCs lack continuity with the 
ER, lack the abundant ER marker protein CaBP3, and ap- 
pear subsequent to the budding of individual vesicles, we 
consider it likely that they represent collection of vesicles en 
route to the cis-Golgi compartment. 
Role of  Ca  2+ in Translmrt 
Both ER to Golgi (Beckers et al., 1990) and intra-Golgi trans- 
port (Schwaninger et al.,  1991; Davidson and Balch, 1993) 
require Ca  2÷. In this paper we have shown that the fusion of 
vesicles or VTCs with the acceptor compartment is the site 
of Ca  2+ dependence.  Accumulation of VTCs was particu- 
larly striking in the absence of Ca  2+ and, like those accu- 
mulated in the presence of the rabl effector domain peptide, 
these VTCs frequently appeared to have a higher content of 
vesicles as opposed to the short, tubular elements observed 
in VTCs formed under normal incubation conditions, sug- 
gesting that Ca  2+ was also required for the fusion of nascent 
vesicles to generate these  tubular elements.  Thus,  VTCs 
principally represent a collection of vesicles en route to the 
perinuclear Golgi. The ability of ER-derived carrier vesicles 
to  form  short  tubules  in  VTCs  may  reflect  the  well- 
documented ability of "like" compartments of the exocytic 
and endocytic pathways to fuse with each other. 
It is now apparent that rab proteins and a family of Ca  2+- 
dependent proteins may specifically regulate the fusion of car- 
rier vesicles  mediating traffic  between many different compart- 
ments of the exocytic pathway (Bennett and Scheller, 1993; 
S61iner et al., 1993).  For example, rabphilin is a Ca2+-bind  - 
ing protein possibly involved in rab3 function (Shiratakis et 
al.,  1993).  Moreover,  several lines of evidence have sug- 
gested a  link between the requirement for Ca  2+ and rabl 
function (Schmitt et al., 1988).  The PMR1 gene in yeast en- 
codes a Ca2+-adenosine triphosphatase (ATPase)  that colo- 
calizes to early Golgi compartments  (Antebi and Fink, 1992). 
Pmrl mutants are strong suppressors of yptM defects in ER to 
Golgi transport (Rudolph et al., 1989),  suggesting that these 
two components function in the context of a protein complex 
that participates in vesicle targeting and/or fusion. In some 
respects, the fusion of  VTCs with the cis-Golgi compartment 
is reminiscent of the rab3/Ca2+-dependent  fusion of vesicles 
to the cell surface during regulated secretion (reviewed in 
Holz et al.,  1991; see Oberhauser et al.,  1992;  Padtield et 
al., 1992; Senyshyn  et al., 1992). However, unlike regulated 
events at the cell surface, which require a transient increase 
in Ca  2+ as part of an upstream signaling pathway,  ER to 
Golgi vesicles and V'ICs function optimally at normal intracel- 
lular (•100  riM)  Ca  2+ concentrations (Beckers and Balch, 
1989; Rexach and Schekman, 1990).  At this time, we prefer 
the model in which both rabl  and a  Ca2+-binding protein 
facilitate the fusion of pre-Golgi carriers to the cis-Golgi 
compartment. 
A Model  for Rabl Function in Vesicle Formation 
and Fusion 
The cumulative evidence from this and previous studies (Tis- 
dale et al., 1992; Davidson and Balch, 1993; Nuoffer et al., 
1994) allows us to propose a tentative working model for the 
function of rabl  in ER to Golgi transport  (Fig.  9).  This 
model, in principle, is also applicable to vesicular traffic be- 
tween early Golgi compartments, We propose that rabl  is 
recruited in the GDP-bound conformation, either as part of 
a  18-19S precoat particle containing/3-COP or in the form 
of  a smaller guanine nucleotide  dissociation inhibitor (GDD- 
rabl  complex (Fig. 9).  The requirement for/3-COP is de- 
rived from our recent observations that a functional pool of 
rabl  involved in vesicle budding is associated with a high 
molecular weight protein complex containing/3-COP (Peter 
et al., 1993). Consistent with these results, we demonstrated 
in the present study that/3-COP is associated with vesicles 
and VTCs containing VSV-G en route to the cis face of the 
Golgi stack in vitro. A similar distribution of B-COP to pre- 
Golgi carriers has been detected in vivo (I-Iendricks et al., 
1993; Oprins et al., 1993;  Pepperkok et al., 1993).  GDI is 
now believed to be associated with the GDP-bound, cyto- 
solic form of rab proteins and to assist in their delivery to 
the membranes (Soldati et al.,  1993;  Ullrich et al.,  1993). 
The possibility that GDI is involved in  an early recruitment 
step is consistent with our observations that a second, low 
molecular weight pool of rabl, which is likely to represent 
a  GDI-rabl  complex (Balch, W.  E.,  and E  Peter, unpub- 
lished observations), can also serve as a source for rabl dur- 
ing vesicle budding from the ER (Peter et al.,  1993).  The 
necessity for recruitment of rabl in the GDP-bound form is 
also consistent with our previous observation that overex- 
pression of rablb(Q67L),  a mutant that is likely to be re- 
stricted to the GTP-bound form because of defective GTP 
hydrolysis, is not a dominant inhibitor of transport in vivo 
(Tisdale et al., 1992), suggesting that it is excluded from the 
Hgure 9. A summary of the role of rabl in the regulation  of vesicles 
and VTCs  mediating vesicular traffic  between the  ER and the 
C-olgi. See text for details. 
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with the observation that recruitment is likely to involve a 
protein (GEP), given the inhibitory properties of the $25N 
mutant which markedly  attenuates export from the ER by 
possibly inhibiting rabl-GEP (Nuoffer et al.,  1994). 
GTP hydrolysis,  presumably mediated by a rabl-specific 
GTPase-activating protein, is likely to be involved in a late 
vesicle  targeting/fusion  step.  This interpretation  is consis- 
tent with the observation that rabl is found on ER to Golgi 
vesicular carriers.  As suggested above, the N124I substitu- 
tion may restrict rabl to a conformation which allows it to 
interact in an irreversible fashion with an effector involved 
in vesicle targeting or fusion (Fig. 9). While the putative tar- 
get for rabl involved in targeting/fusion is unknown, recent 
studies have found that H-ras(N116I)  can form a complex 
with a purified ras-specific GEP (Hwang et al., 1993). These 
results raise the possibility that the N124I mutant can at least 
interact and be recruited by a rabl-GEP during vesicle bud- 
cling.  However,  the mode of interaction  of the  $25N  and 
N124I mutants with GEP and/or other transport components 
are clearly different in that the two mutants diverge with re- 
spect to their requirements for posttranslational isoprenyla- 
tion,  competition  with wild type rabl,  and morphological 
phenotypes.  One possibility  to account for these results is 
that while the $25N mutant reduces the overall activity or 
efficiency of rabl-GEP in promoting wild type rabl recruit- 
ment, the N124I mutant adopts a conformation that supports 
its  efficient  recruitment  during coat assembly  and vesicle 
budding, but renders it unable to undergo a critical confor- 
mational change required to initiate vesicle targeting/fusion 
(Fig. 9). Since both mutants lead to inhibition of intra-Golgi 
transport and loss of the Golgi  stack in a  fashion distinct 
from that observed for brefeldin A  or microtubule depoly- 
merizing agents such as nocodazole (Nuoffer et al.,  1994; 
Balch, W. E., unpublished results), it is apparent that the in- 
tegrity of the Golgi stack is exceptionally sensitive to the dis- 
ruption of vesicular traffic between compartments (see Wil- 
son et al.,  1994). 
Given the complexities of events involved in vesicle bud- 
ding and fusion, further experiments are currently in prog- 
ress to identify rabl-GEP and the targeting/fusion machinery 
regulated by rabl  and rabl-speciiic  GTPase-activating  pro- 
tein. With these components in hand, we should be able to 
refine the above working model,  which  is largely  derived 
from the use of selected mutants defective in guanine nucleo- 
tide exchange and hydrolysis. 
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